Candel Therapeutics
CADL
CADL
21 hedge funds and large institutions have $9.7M invested in Candel Therapeutics in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
49% less capital invested
Capital invested by funds: $19.1M → $9.7M (-$9.4M)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
21
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$46.7K | |
| 2 | +$24K | |
| 3 | +$5.54K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.2K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$526 |
Top Sellers
| 1 | -$1.27M | |
| 2 | -$290K | |
| 3 | -$154K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$53K |
| 5 |
Millennium Management
New York
|
-$47K |